David Lillicrap, MD

Professor
Department of Pathology and Molecular Medicine, Queen's University

David Lillicrap is a Professor in the Department of Pathology and Molecular Medicine at Queen’s University, Kingston, Canada. He is the recipient of a Senior Canada Research Chair in Molecular Hemostasis. In 2013, he was elected to the Fellowship of the Royal Society of Canada. Dr Lillicrap is a past member of the World Federation of Hemophilia’s (WFH) Medical Advisory Board and a past Chair of the WFH’s Research Committee. He is a past Chairman of the International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee and member of the Council of ISTH. Between 2008–2014 he served as an Associate Editor of Blood and is currently Co Editor in-Chief of the Journal of Thrombosis and Haemostasis.

Dr Lillicrap’s research interests are centered on molecular aspects of the haemostatic system, with a particular emphasis on the potential of molecular genetics and molecular biology to address questions relating to pathological haemostasis. The main foci of interest of his research group are the investigation of the immune response to factor VIII (FVIII), the development and evaluation of novel therapies for haemophilia A, and characterisation of the biology and pathobiology of von Willebrand factor.

Presentation(s):

• PUB 01.2 - Peer Reviewing for ISTH Journals

  Saturday, July 9, 2022
  11:15 AM – 11:30 AM

• OC 01.5 - Innate and Adaptive Immune Responses to Adeno-Associated Viral Gene Therapy in the Severe Hemophilia A Dog Model

  Saturday, July 9, 2022
  2:00 PM – 2:15 PM

• OC 37.3 - Mice possess a more limited natural anti-FVIII antibody repertoire than humans that is generated primarily by marginal zone B cells

  Monday, July 11, 2022
  11:15 AM – 11:30 AM

• SS 17.2 - Evolving Treatment Goals Towards Normalisation

  Monday, July 11, 2022
  1:25 PM – 2:25 PM

• PB0802 - The VWF Propeptide Is A Novel Component Of Venous Thrombi In A Mouse Model Of DVT

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 53.3 - Syntaxin-2 deficiency results in reduced von Willebrand factor expression in vitro and in vivo

  Tuesday, July 12, 2022
  11:15 AM – 11:30 AM

• PB1081 - Optimizing Variant Curation Guidelines to Improve Clinical Genetic Testing and Diagnosis of von Willebrand Disease

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1146 - Determinants of successful immune tolerance induction in persons with hemophilia A – systematic review and meta-analysis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM